Terms: = Breast cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Clinical Outcome
78 results:
1. Two-Dimensional-PAGE Coupled with nLC-MS/MS-Based Identification of Differentially Expressed Proteins and Tumorigenic Pathways in MCF7 breast cancer Cells Transfected for JTB Protein Silencing.
Jayathirtha M; Jayaweera T; Whitham D; Sullivan I; Petre BA; Darie CC; Neagu AN
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005222
[TBL] [Abstract] [Full Text] [Related]
2. PSMG2-controlled proteasome-autophagy balance mediates the tolerance for MEK-targeted therapy in triple-negative breast cancer.
Wang X; Yu J; Liu X; Luo D; Li Y; Song L; Jiang X; Yin X; Wang Y; Chai L; Luo T; Jing J; Shi H
Cell Rep Med; 2022 Sep; 3(9):100741. PubMed ID: 36099919
[TBL] [Abstract] [Full Text] [Related]
3. TRAF4 hyperactivates HER2 signaling and contributes to Trastuzumab resistance in HER2-positive breast cancer.
Gu Y; Gao H; Zhang H; John A; Zhu X; Shivaram S; Yu J; Weinshilboum RM; Wang L
Oncogene; 2022 Aug; 41(35):4119-4129. PubMed ID: 35864174
[TBL] [Abstract] [Full Text] [Related]
4. Withaferin A mediated changes of miRNA expression in breast cancer-derived mammospheres.
Prajapati KS; Shuaib M; Gupta S; Kumar S
Mol Carcinog; 2022 Sep; 61(9):876-889. PubMed ID: 35770722
[TBL] [Abstract] [Full Text] [Related]
5. Co-targeting CDK4/6 and akt with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer.
Alves CL; Ehmsen S; Terp MG; Portman N; Tuttolomondo M; Gammelgaard OL; Hundebøl MF; Kaminska K; Johansen LE; Bak M; Honeth G; Bosch A; Lim E; Ditzel HJ
Nat Commun; 2021 Aug; 12(1):5112. PubMed ID: 34433817
[TBL] [Abstract] [Full Text] [Related]
6. Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. clinical outcome and actionable molecular alterations.
Conforti F; Pala L; Pagan E; Rocco EG; Bagnardi V; Montagna E; Peruzzotti G; De Pas T; Fumagalli C; Pileggi S; Pesenti C; Marchini S; Corso G; Marchio' C; Sapino A; Graffeo R; Collet L; Aftimos P; Sotiriou C; Piccart M; Gelber RD; Viale G; Colleoni M; Goldhirsch A
Breast; 2021 Oct; 59():94-101. PubMed ID: 34217971
[TBL] [Abstract] [Full Text] [Related]
7. S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2/FGFR1 Signaling Pathway in Triple-Negative breast cancer (TNBC) Cells.
Santolla MF; Talia M; Maggiolini M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946884
[TBL] [Abstract] [Full Text] [Related]
8. SENP3 loss promotes M2 macrophage polarization and breast cancer progression.
Xiao M; Bian Q; Lao Y; Yi J; Sun X; Sun X; Yang J
Mol Oncol; 2022 Feb; 16(4):1026-1044. PubMed ID: 33932085
[TBL] [Abstract] [Full Text] [Related]
9. Transmembrane and coiled-coil domain family 3 (TMCC3) regulates breast cancer stem cell and akt activation.
Wang YH; Chan YT; Hung TH; Hung JT; Kuo MW; Wang SH; Huang Y; Lin YJ; Chen SC; Yu JC; Wu JC; Yu J; Yu AL
Oncogene; 2021 Apr; 40(16):2858-2871. PubMed ID: 33742122
[TBL] [Abstract] [Full Text] [Related]
10. Mutant TP53 interacts with BCAR1 to contribute to cancer cell invasion.
Guo AK; Itahana Y; Seshachalam VP; Chow HY; Ghosh S; Itahana K
Br J Cancer; 2021 Jan; 124(1):299-312. PubMed ID: 33144694
[TBL] [Abstract] [Full Text] [Related]
11. Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance.
Li L; Lin L; Veeraraghavan J; Hu Y; Wang X; Lee S; Tan Y; Schiff R; Wang XS
Breast Cancer Res; 2020 Aug; 22(1):84. PubMed ID: 32771039
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological Evaluation of the Potential Anatomic Pathways of Systemic Metastasis from Primary breast cancer Suggests an Orderly Spread Through the Regional Lymph Nodes.
David Nathanson S; Leonard-Murali S; Burmeister C; Susick L; Baker P
Ann Surg Oncol; 2020 Nov; 27(12):4810-4818. PubMed ID: 32720039
[TBL] [Abstract] [Full Text] [Related]
13. A nuclear lncRNA Linc00839 as a Myc target to promote breast cancer chemoresistance via PI3K/akt signaling pathway.
Chen Q; Shen H; Zhu X; Liu Y; Yang H; Chen H; Xiong S; Chi H; Xu W
Cancer Sci; 2020 Sep; 111(9):3279-3291. PubMed ID: 32619088
[TBL] [Abstract] [Full Text] [Related]
14. Molecular stratification within triple-negative breast cancer subtypes.
Wang DY; Jiang Z; Ben-David Y; Woodgett JR; Zacksenhaus E
Sci Rep; 2019 Dec; 9(1):19107. PubMed ID: 31836816
[TBL] [Abstract] [Full Text] [Related]
15. Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.
Nan X; Wang J; Cheng H; Yin Z; Sheng J; Qiu B; Lau CC; Yustein JT; Zhao H; Wong STC
Cancer Lett; 2020 Jan; 469():195-206. PubMed ID: 31672491
[TBL] [Abstract] [Full Text] [Related]
16. Role of miRNA-Regulated cancer Stem Cells in the Pathogenesis of Human Malignancies.
Khan AQ; Ahmed EI; Elareer NR; Junejo K; Steinhoff M; Uddin S
Cells; 2019 Aug; 8(8):. PubMed ID: 31530793
[TBL] [Abstract] [Full Text] [Related]
17. GATA1 promotes colorectal cancer cell proliferation, migration and invasion via activating akt signaling pathway.
Yu J; Liu M; Liu H; Zhou L
Mol Cell Biochem; 2019 Jul; 457(1-2):191-199. PubMed ID: 31069596
[TBL] [Abstract] [Full Text] [Related]
18. The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype.
Veenstra C; Karlsson E; Mirwani SM; Nordenskjöld B; Fornander T; Pérez-Tenorio G; Stål O
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1845-1856. PubMed ID: 31025094
[TBL] [Abstract] [Full Text] [Related]
19. Improving surgical efficiency of immediate implant-based breast reconstruction following mastectomy.
Nealon K; Rebello M; Sobti N; Sherburne A; Spracklin D; Liao EC; Specht M
Breast Cancer Res Treat; 2019 Jul; 176(1):159-164. PubMed ID: 30977025
[TBL] [Abstract] [Full Text] [Related]
20. Dissecting the predictive value of MAPK/akt/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES.
Szijgyarto Z; Flach KD; Opdam M; Palmieri C; Linn SC; Wesseling J; Ali S; Bliss JM; Cheang MCU; Zwart W; Coombes RC
Breast Cancer Res Treat; 2019 May; 175(1):149-163. PubMed ID: 30680659
[TBL] [Abstract] [Full Text] [Related]
[Next]
